- Fanconi Anemia, Complementation Group D1 Caused by Biallelic Mutations of BRCA2 Gene - Case Report2016 | Second Faculty of Medicine
- Screening for germline mutations in BRCA1 and BRCA2 genes in Czech republicPublication without faculty affiliation
- Screening for germline mutations in BRCA1 and BRCA2 genes in Czech republic2001 | Faculty of Physical Education and Sport
- Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene2010 | First Faculty of Medicine
- Preservation of fertility in young patients with breast cancer, including BRCA1, BRCA2 mutation carriers2023 | First Faculty of Medicine
- The role of BRCA1 and BRCA2 genes in breast cancer developmentPublication without faculty affiliation
- Inactivation of BRCA1 and BRCA2 genes in sporadic breast carcinomaPublication without faculty affiliation
- Novel somatic mutations of the BRCA1 and BRCA2 genes in sporadic breast cancerPublication without faculty affiliation
- Role of somatic mutations in BRCA1 and BRCA2 genes in sporadic cancer developmentPublication without faculty affiliation
- Mutation analysis of BRCA1 and BRCA2 genes in the hereditary breast and ovarian cancerPublication without faculty affiliation
- Oncopathological aspects of BRCA1 and BRCA2 genes inactivation in tumors of ovary, fallopian tube and pelvic peritoneum2016 | First Faculty of Medicine, Second Faculty of Medicine
- Splicing variants of BRCA1 and BRCA2 genes identified in high-risk Czech breast and ovarian cancer familiesPublication without faculty affiliation
- Hereditary breast cancer - an example of uncommon breast cancer in population2009 | First Faculty of Medicine
- Serous tubal intraepithelial carcinoma2018 | First Faculty of Medicine
- Gynecological Care and Prevention of Gynecological Malignancies in BRCA1 and BRCA2 Mutation Carriers2016 | First Faculty of Medicine
- 14th IFCC-FESCC European Congres of Clinical Screening for germline2002 | First Faculty of Medicine
- 14th IFCC-FESCC European Congres of Clinical Screening for germline2002 | Faculty of Physical Education and Sport
- Genetic testing in ovarian cancer2022 | First Faculty of Medicine
- Platinum-sensitive recurrent ovarian cancer and olaparib maintenance treatment - case report2019 | First Faculty of Medicine
- Study of Selected BRCA1, BRCA2, and PIK3CA Mutations in Benign and Malignant Lesions of Anogenital Mammary-Like Glands2017 | Faculty of Medicine in Pilsen
- Niraparib2021 | First Faculty of Medicine
- Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic2016 | First Faculty of Medicine
- DNA Repair Pathway in Ovarian Cancer Patients Treated with HIPEC2023 | Faculty of Medicine in Pilsen, Central Library of Charles University
- Mutation Analysis of the RAD51C and RAD51D Genes in High-Risk Ovarian Cancer Patients and Families from the Czech Republic2015 | First Faculty of Medicine
- The AIB1 gene polyglutamine repeat length polymorphism and the risk of breast cancer development2011 | First Faculty of Medicine
- Bilateral Prophylactic Nipple-Sparing Mastectomy: Analysis of the Risk-Reducing Effect in BRCA1/2 Mutation Carriers2022 | First Faculty of Medicine
- Testing of mutations in BRCA1 and BECA2 genes in tumor tissues - possibilities and limitations2016 | Faculty of Medicine in Hradec Králové
- Comparative analysis of loss of heterozygosity and expression profi le in normal tissue, DCIS and invasive breast cancer2011 | First Faculty of Medicine
- Recommendations for Preventive Care for Women with Rare Genetic Cause of Breast and Ovarian Cancer2019 | First Faculty of Medicine
- BRCA mutation carriers suffering from ovarian cancer as a model for treatment decision in higher lines - Place for platinum reinduction2023 | First Faculty of Medicine, Third Faculty of Medicine